Showing results (2061-2070 of 2,307) with videos related to

Sort By:
Pageof 231
NPJ Biofilms and Microbiomes|January 3, 2023
Gut microbiome dysregulation drives bone damage in broiler tibial dyschondroplasia by disrupting glucose homeostasisTing-Ting Xu, Pan Chen, Chao-Dong Zhang, et al.
Blood|August 19, 2010
Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasiaPeter D Burbelo, Sarah K Browne, Elizabeth P Sampaio, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2017
Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of functionElizabeth P Sampaio, Li Ding, Stacey R Rose, et al.
Cancer Research Communications|May 8, 2024
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft ModelsZhanfang Guo, Jingqin Luo, R Jay Mashl, et al.
Blood|September 30, 2010
Complete characterization of the microRNAome in a patient with acute myeloid leukemiaGiridharan Ramsingh, Daniel C Koboldt, Maria Trissal, et al.
Science (New York, N.Y.)|June 30, 2012
Landscape of somatic retrotransposition in human cancersEunjung Lee, Rebecca Iskow, Lixing Yang, et al.
Iscience|January 23, 2025
Germline predisposition in multiple myelomaFernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.
Ebiomedicine|March 20, 2026
Clinical characteristics and molecular epidemiology of KPC-NDM co-producing carbapenem-resistant Klebsiella pneumoniae in China: a multicentre retrospective case-control studyXi Li, Xinhong Han, Xinyan Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2008
The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer developmentTyson V Sharp, Ahmad Al-Attar, Daniel E Foxler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2019
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage ResponseLi Ding, Vijay S Madamsetty, Spencer Kiers, et al.
Pageof 231